Search Results for: "Other News to Note"
-
Other News To Note
In addition, Kamada has granted the underwriters a 30-day option to purchase up to an additional 837,395 shares of common stock to cover overallotments, if anyBioWorld International | Wednesday, June 12, 2013 -
Other News To Note
Effective on that date, its common stock now trades for quotation on the OTCQB, an electronic quotation service operated by OTC Markets Group Inc...The company expects that its common stock will also trade on the OTC Bulletin BoardBioWorld Today | Monday, June 10, 2013 -
Other News To Note
The company expects its common stock to begin trading on the NYSE market on June 17, under its current ticker symbol, "AMPEBioWorld Today | Friday, June 7, 2013 -
Other News To Note
Novavax Inc., of Rockville, Md., made a public tender offer to acquire the outstanding shares and warrants of Isconova AB, of Uppsala, Sweden, offering 1.2388 shares of its common stock for each share in Isconova and SEK 140,277 (US$21,377) for 2005-I warrants and 2005-II warrants in Isconova...Novavax said it plans to make a separate, private offer for outstanding stock options, issuing 218,120 shares of Novavax common stock, corresponding to a value of SEK 8.30 (US$1 .26) for each option shareBioWorld Today | Wednesday, June 5, 2013 -
Other News To Note
Maxygen estimated that the aggregate amount of the initial liquidating distribution to stockholders will be between $68.2 million and $69.6 million, or between $2.45 to $2.50 per share, based on about 27 million shares of common stock outstanding as of May 31...Ohr Pharmaceutical Inc., of New York, (NASDAQ:OHRPD) said it has undertaken a 1-for-3 reverse split of its issued and outstanding common stockBioWorld Today | Tuesday, June 4, 2013 -
Pharma: Other News To Note
Perrigo Co., of Allegan, Mich., is transferring the listing of its U.S.-traded common stock to the New York Stock Exchange (NYSE) from NasdaqBioWorld Today | Friday, May 24, 2013 -
Other News To Note
Also, it revises the proposal to decrease the total number of authorized shares of common stock, dropping the total number of authorized shares of common stock post-reverse stock split to 50 million shares (in the earlier proxy, Advaxis proposed a total number of 300 million shares of common stock post-reverse stock splitBioWorld Today | Friday, May 24, 2013 -
Pharma: Other News To Note
Pfizer will conduct an exchange offer, in which its shareholders can exchange all, some or none of their shares of Pfizer common stock for shares of Zoetis common stock owned by PfizerBioWorld Today | Thursday, May 23, 2013 -
Other News To Note
The court found that Emmaus had properly canceled all shares of its common stock held by AFH and that AFH and Heshmatpour must return to Emmaus all stock certificates representing the sharesBioWorld Today | Friday, May 17, 2013 -
Pharma: Other News To Note
The company plans to use proceeds to repurchase common stock and for general corporate purposes, including the repayment of outstanding commercial paper borrowings and upcoming debt maturitiesBioWorld Today | Friday, May 17, 2013 -
Other News To Note
Common stock in Fibrocell Science Inc., of Exton, Pa., has been approved for listing on the NYSE Market, to commence trading on May 17, under the ticker symbol FCSCBioWorld Today | Thursday, May 16, 2013 -
Other News To Note
Aastrom Biosciences Inc., of Ann Arbor, Mich., reported in an 8-K filing with the SEC that it was notified by Nasdaq that the bid price for its common stock closed below the minimum $1 per share requirement for 30 consecutive business daysBioWorld Today | Tuesday, May 14, 2013 -
Other News To Note
The split is intended to increase the per-share trading price of the common stock to satisfy the $1 minimum bid price requirement for continued listing on the Nasdaq Capital Market...Trading of the company's common stock on the Nasdaq Capital Market will continue, on a split-adjusted basis, with the opening of the markets on May 13, under new CUSIP number 69207P308BioWorld Today | Monday, May 13, 2013 -
Pharma: Other News To Note
Inc., of Whitehouse Station, N.J., said its board authorized additional purchases of up to $15 billion of Merck's common stock for its treasury...The company expects to repurchase about $7.5 billion of common stock over the next 12 months, financed through a combination of debt issuance and operating cash flows, with the remainder to be repurchased over time with no time limitBioWorld Today | Thursday, May 2, 2013 -
Other News To Note
Soligenix also will issue 1 million shares of its common stock to Intrexon, representing 8.5 percent of its outstanding shares, and provide Intrexon with the right to participate in future offerings and to purchase the company's shares in the open market...Tonix Pharmaceuticals Holdings Corp., of New York, said it effected a 1-for-20 reverse stock split, effective May 1, as a step toward its intention to list its common stock on NasdaqBioWorld Today | Thursday, May 2, 2013 -
Other News To Note
26, 2017, at an interest rate of 13 percent, and the conversion rate will be re-priced from $3.78 to $1.25 per share of common stockBioWorld Today | Tuesday, April 30, 2013 -
Other News To Note
OvaScience, of Cambridge, Mass, said its common stock was approved for listing on Nasdaq under the ticker "OVAS" and will start trading April 30BioWorld Today | Friday, April 26, 2013 -
Pharma: Other News To Note
AMC approval is one of the conditions for consummation of its tender offer for all outstanding shares of common stock in Obagi at $24 per shareBioWorld Today | Thursday, April 25, 2013 -
Other News To Note
Based upon the number of shares of Tranzyme common stock to be issued in the merger, current Tranzyme shareholders will own about 27 percent of the company, and current Ocera shareholders will own the restBioWorld Today | Thursday, April 25, 2013 -
Other News To Note
Zalicus Inc., of Cambridge, Mass., received notification from Nasdaq that the company's application to list its common stock on the Nasdaq Capital Market has been approved, and that the company's securities will be transferred from the Nasdaq Global Market at the opening of trading on April 23BioWorld Today | Monday, April 22, 2013
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.